Adma Biologics, Inc.
ADMA· Nasdaq
Released May 15, 2012, after the close
10-Q filed May 15, 2012, 45 days after period end · 0001193805-12-000925
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $4.40K | $0.00 |
| Net Income | -$597.31K | -$1.58M |
| EPS Diluted | -$0.18 | -$4.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end